Roche's Third Quarter Results 2022
Agenda
Overview
Pharmaceuticals Division
Diagnostics Division
Financial Results
Questions and answers
Bruno Eschli, Head of Investor Relations
Bill Anderson, CEO Roche Pharmaceuticals
Thomas Schinecker, CEO Roche Diagnostics
Alan Hippe, Chief Financial and IT Officer

Please register to access the replay*

*Privacy notice

Investors
Past IR Events
View more Events

Roche has published its Third Quarter Sales results for 2022 prior to the opening of the Swiss Stock Exchange on Tuesday, 18th October 2022. Please register to access the replay of the webinar.

Downloads

Discover more